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Edited by Gianni CesareniAbstract The intracellular domain (ICD) of the low-density
lipoprotein receptor-related protein (LRP) functionally interacts
with adaptor proteins both as an integral part of the receptor
polypeptide and after proteolytic release. Identiﬁcation of such
adaptors has been diﬃcult because the ICD is self-activating
in conventional transcription factor-based yeast two-hybrid
screens. We adopted an alternative screen for the ICD that
depends on the activation of the Ras-signaling pathway and
uncovered the transcription factor MafB as novel ICD interact-
ing protein. MafB is a regulator of hindbrain segmentation and
interacts with the ICD through a leucine zipper domain. The
ICD co-localizes with MafB to the nucleus and negatively
regulates its transcriptional activity, suggesting a possible role
for LRP in brain development.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The low-density lipoprotein (LDL) receptor-related protein
(LRP) is a 600 kDa cell surface receptor structurally related to
the LDL receptor [1]. It constitutes a multifunctional receptor
pathway that binds many ligands and aﬀects various activities
in tissues that express the protein [2,3]. In hepatocytes, LRP
acts as a clearance receptor for chylomicron remnants, lipo-
proteins carrying dietary lipids [4]. In vascular smooth muscle
cells, it regulates the activity of the platelet-derived growth
factor receptor-b and aﬀects atherosclerotic lesion formation
[5–7], while in neurons it modulates processing of the amyloid
precursor protein (APP) and may play a role in Alzheimer’s
disease [8,9]. The embryonic lethality in mice with LRP gene
defect suggests additional functions during development that
still await further elucidation [10].
Recently, much attention has been focused on the intracel-
lular domain (ICD) of LRP as an important determinant of
receptor activity. This domain consists of 100 amino acids that* Corresponding author. Fax: +49-30-9406-3382.
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Among others, it includes two NPXY elements that are subject
to tyrosine phosphorylation and constitute binding sites for
proteins with phosphotyrosine binding (PTB) domain
[5,7,11,12]. Through binding of adaptor proteins, the ICD
forms multimeric protein complexes at the plasma membrane
that are considered crucial for the various receptor activities
[2,3]. In addition, this domain can be cleaved from the receptor
and act as a modulator of transcription by yet unknown
mechanisms [13,14].
Given the central role of protein–protein interactions at the
ICD, identiﬁcation of binding partners for the receptor tail
remains an important task in elucidating the molecular details
of receptor function. This task has been confounded by the
fact that the LRPICD is self-activating in conventional yeast
two-hybrid screens that rely on the assembly of an active
transcription factor through interaction of the receptor tail
(bait) with target proteins (prey) [12]. Therefore, this technol-
ogy, though widely used to identify novel interaction partners,
is not applicable to LRP. Alternative strategies to uncover
ICD interacting proteins included the co-puriﬁcation of the
receptor with adaptor proteins such as the PTB-domain pro-
tein Shc [11], or the test of candidate adaptors that bound to
related receptors using pull-down experiments [12,15].
Because previous candidate-based approaches for interact-
ing proteins may have been biased by our limited knowledge of
the receptor biology, we sought to apply an alternative system
that would allow an unbiased screen for novel and unexpected
interaction partners for the LRPICD. We successfully used a
yeast two-hybrid screen that is based on functional interact-
ions in the Ras-signaling pathway and depends on the as-
sembly of protein complexes at the plasma membrane rather
than the nucleus. In this screen, we identiﬁed the transcription
factor MafB as LRP interacting protein. MafB is a regulator of
hindbrain development and interacts with the LRPICD
through a basic region linked to a leucine zipper domain
(bZIP). LRPICD co-localizes with MafB to the nucleus and
negatively regulates its transcriptional activity.2. Materials and methods
2.1. Materials
An expression construct encoding the PTB domain of mammalian
disabled 1 (Dab1), fused with glutathione-S transferase (GST), wasblished by Elsevier B.V. All rights reserved.
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full-length murine MafB cDNA was produced by RT-PCR from
mouse liver RNA.
2.2. Yeast two-hybrid screen
Starting from a mouse LRP cDNA sequence [16], a LRPICD
encoding fragment (amino acids 4446–4545) was generated by a PCR
approach, cloned into vector pSos (LRPICD/pSos, Stratagene,
www.stratagene.com) and used as a bait to screen a human fetal brain
library (No. 975230) according to the manufacturer’s recommenda-
tions (CytoTrapTM, Stratagene). Positive clones were isolated from the
yeast strain cdc25H and their interaction with the LRPICD conﬁrmed
by retransformation of the plasmids in the presence of either LRPICD/
pSos or pSos. Truncations of clone 17 were generated by PCR cloning
approach, introduced into target vector pMyr, and their interactions
with LRPICD determined by transformation of the respective con-
structs into yeast strain cdc25H.
2.3. Expression of recombinant proteins
GST and GST-fusion proteins of clone 17 or murine MafB were
obtained by cloning of the respective gene sequences into vector
pGEX-4T-1 (Amersham, www.amershambiosciences.com) and
expression in DH5a bacteria. Recombinant proteins were puriﬁed
by glutathione–agarose aﬃnity chromatography. A fusion of the
LRPICD with a hexa-histidine epitope (His-LRPICD) was produced
by cloning of the ICD encoding sequence into vector pET16b
(Novagen, www.novagen.com) and by puriﬁcation of the fusion pro-
tein from BL21 bacteria via routine Ni–NTA aﬃnity chromatography.
2.4. In vitro protein interaction
Ligand blot analysis was performed as described [17]. Iodination of
His-LRPICD followed the protocol of Fraker and Speck [18]. For
surface plasmon resonance analysis, puriﬁed His-LRPICD was immo-
bilized on the CM5 sensor chip surface and incubated with the indicated
concentrations of GST-clone 17 or GST-Dab1 as published [17].
2.5. Immunocytochemistry
The MafB encoding cDNA sequence was introduced into vector
pEGFP-C1 (BD Biosciences, www.bdbiosciences.com) and expressed
as a fusion with the enhanced green ﬂuorescent protein (EGFP).
Sequences encoding LRPICD were cloned into pDsRed2-C1 (BD
Biosciences) and expressed as fusion with the Discosoma red ﬂuorescent
protein (DsRed2). For expression studies, HEK 293 cells were trans-
fected with 0.5 lg/12-well of the plasmids by liposomal transfection
technology (Fugene 6; Roche, www.roche.com). Expression and sub-
cellular localization of the proteins were conﬁrmed by confocal ﬂuo-
rescence microscopy (Leica TCS SP2).
2.6. Reporter gene assay
The reporter gene plasmid was produced by introducing an oligo-
nucleotide sequence containing three consecutive repeats of a Maf
recognition element (MARE) into the pTALSEAP vector (BD Bio-
sciences) driving expression of the secreted human placental alkaline
phosphatase (SEAP) gene (MARE/pTALSEAP). Following transfec-
tion of HEK 293 cells (48 h), cell pellets and conditioned medium were
harvested for reporter gene assays. Conditioned medium was processed
according to the manufacturer’s instructions and SEAP activity as-
sayed using the EscAPeTM SEAP system (BD Biosciences). For control
of transfection eﬃciency, transfection mixtures included pCMV-b-gal
that encodes the b-galactosidase gene under control of the Cytomeg-
alovirus promoter element (Stratagene). After removal of the condi-
tioned medium, cells were washed once with PBS, lysed in 100 ll of
reporter lysis buﬀer (Promega, www.promega. com) per 12-well, and
processed according to manufacturer’s instructions (Luminiescent
b-gal, BD Biosciences).3. Results
To circumvent the problem of self-activation of the LRPICD
in conventional yeast two-hybrid screen (e.g., lexA system), we
explored the use of the CytoTrapTM system to screen for LRP
interacting proteins. To do so, we expressed the LRPICD as afusion protein with the human son of sevenless (hSos) gene
product (LRPICD/pSos) and screened a human fetal brain
library where target proteins are tethered to the plasma
membrane via a myristylation sequence (pMyr). Functional
interaction of LRPICD with target proteins would locate the
LRPICD/hSos fusion protein to the plasma membrane, re-
constituting the Ras-signaling pathway by functionally replac-
ing the yeast Sos homologue that is defected in the yeast strain
cdc25H.
No functional reconstitution of the Ras-pathway was ob-
served when cdc25H cells were transfected with LRPICD/pSos
alone, but ﬁve positive clones were obtained when co-trans-
fected with the cDNA library in vector pMyr (data not
shown). Three clones encoded the EB1 protein, an interaction
partner of the APC tumor suppressor protein [19]. The other
two clones contained a partial cDNA sequence, encoding the
truncated MafB protein lacking the ﬁrst 147 residues of the 323
amino acid polypeptide (provisionally designated clone 17)
(Fig. 1). MafB belongs to the Maf protein family of tran-
scription factors that are characterized by the presence of a
bZIP [20,21]. The basic region binds to MARE in the DNA,
whereas the leucine zipper domain enables interaction with
other proteins. In addition, full-length MafB encompasses an
activation domain and two histidine repeats (Fig. 1). Muta-
tions in the murine MafB gene are responsible for the mouse
mutant Kreisler, a developmental defect of the hindbrain [20].
Because the LRPICD is known to undergo proteolytic
processing and translocation into the nucleus, we focused
further attention on a possible interaction of the LRPICD with
the transcription factor MafB. First, we conﬁrmed the inter-
action of MafB with the receptor employing ligand blot and
surface plasmon resonance (BIAcore) analysis. To do so, a
fusion protein of GST and clone 17 (GST-clone 17) was ex-
pressed and puriﬁed from bacterial extracts by glutathione–
agarose aﬃnity chromatography (Fig. 2, lane 3). As a positive
control, we expressed a fusion of GST with the PTB domain of
Dab1, an established adaptor of LRP [12] (Fig. 2, lane 2). By
ligand blot analysis, we demonstrated binding of soluble
LRPICD to GST-clone 17 and GST-Dab1 but not to GST
(Fig. 2, lanes 4–6). This interaction could be conﬁrmed by
surface plasmon resonance analysis. Using a concentration
series, a Kd of 1 lM was determined for binding of the soluble
GST-clone 17 to the LRPICD immobilized on the biosensor
chip surface (Fig. 3A). The same aﬃnity was obtained when
using the full-length LRP puriﬁed from rat liver (data not
shown). As a control, a Kd of 0.3 lM was determined for
binding of GST-Dab1 to the LRPICD (Fig. 3B). GST alone
did not interact with the receptor (not shown).
To test whether LRPICD and MafB co-localized in cells, we
generated fusion proteins of full-length murine MafB with the
EGFP and LRPICD with DsRed2 ﬂuorescent protein and
expressed them in HEK 293 cells. Using confocal ﬂuorescence
microscopy, EGFP-MafB was detected exclusively in the nu-
cleus of the cells, whereas DsRed2-LRPICD was seen both in
the cytoplasm and in the nucleus, where it co-localized with
EGFP-MafB (Fig. 4).
To determine whether a functional interaction exists
between LRP and MafB in the nucleus, we tested the eﬀect of
LRPICD on MafB activity using reporter gene assays. We
generated a reporter construct containing three copies of a
MARE sequence that determines recognition by Maf proteins
(TGCTTACTAAGCA) [22], followed by a TATA-like pro-
Fig. 1. Sequence and structure analysis of MafB. The amino acid se-
quences of the human and mouse MafB proteins are depicted. Boxed
sequences highlight (from amino to carboxyl terminus) the ﬁrst and the
second histidine-rich repeats as well as the bZIP. Underlined sequences
indicate the partial MafB clone (clone 17) isolated from a human fetal
brain library (amino acids 148–323).
Fig. 3. Surface plasmon resonance analysis of LRPICD and clone 17
interactions. His-LRPICD immobilized on the BIAcore sensor chip
surface was incubated with the indicated concentrations of puriﬁed
GST-clone 17 (A) or GST-Dab1 (B). Binding to LRPICD was detected
by surface plasmon resonance analysis and indicated in response units.
Fig. 2. Ligand blot analysis of LRPICD and clone 17 interactions. Ten
microgram of puriﬁed GST (lanes 1 and 4), GST-Dab1 (lanes 2 and 5),
and GST-clone 17 (lanes 3 and 6) was subjected to reducing 10% SDS–
PAGE and staining with Coomassie (lanes 1–3) or transfer to nitro-
cellulose membrane and ligand blot analysis with 125I His-LRPICD
(lanes 4–6). Binding of 125I His-LRPICD to GST-clone 17 and GST-
Dab1, but not to GST, was detected by autoradiography.
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promoter driving expression of the SEAP gene product. In
these assays, MafB stimulated expression of SEAP as
demonstrated by a 3-fold increase in enzyme activity, in
accordance with previous data [22] (Fig. 5, column 2).
Co-transfection of MafB and LRPICD resulted in a moderate
but signiﬁcant reductionof the transactivationpotential ofMafB
(column 4), whereas LRPICD alone had no aﬀect (column 3).
To map the binding site for LRPICD on the MafB poly-
peptide, we generated truncations of human clone 17 and the
murine MafB sequence lacking the bZIP domain (Fig. 6A) and
tested their interaction with LRPICD in the yeast two-hybridsystem (Fig. 6A) and ligand blot analysis (Fig. 6B), respec-
tively. No interaction of LRPICD with truncated gene prod-
ucts could be detected in both assays. Deletion of the leucine
zipper but not the basic region also abolished interaction with
LRPICD (data not shown), demonstrating that MafB binds to
the receptor tail through its leucine zipper motif.4. Discussion
Interactions of the LRPICD with cytosolic adaptor proteins
are considered crucial for receptor function but much of the
Fig. 4. Co-localization of MafB with LRPICD in HEK 293 cells. Cells
were transiently transfected with constructs encoding fusions of the
EGFP with MafB (EGFB-MafB) and the DsRed2 with LRPICD
(DsRed2-LRPICD). Subcellular localization of the expressed proteins
was detected 48 h later by confocal ﬂuorescence microscopy.
Fig. 5. Eﬀect of LRPICD on MafB activity. HEK 293 cells were
transfected with reporter plasmid MARE/pTALSEAP and pCMV-
b-gal (control of transfection eﬃciency). Where indicated, the trans-
fection mixture also included MafB and/or LRPICD expression
constructs. MafB-dependent expression of SEAP from plasmid
MARE/pTALSEAP was determined and corrected for transfection
eﬃciency as indicated by b-galactosidase activity. The relative light
units obtained in the absence of MafB and LRPICD (column 1) was
set at 1. A signiﬁcant reduction in MafB-induced activation of the
MARE/pTALSEAP was observed in the presence of LRPICD (col-
umn 4) (P ¼ 0:007, Student’s t-test). Data are from ﬁve independent
experiments run in duplicates.
Fig. 6. Mapping of the LRPICD binding site on MafB. (A) A sche-
matic presentation of the structure of MafB is indicated together with
the extension of clone 17, truncated clone 17 (D clone 17), murine
MafB and truncated MafB (DMafB). Whereas the interaction of clone
17 with LRPICD was shown in the yeast two-hybrid system, no in-
teraction could be detected using D clone 17. n.d., not determined. (B)
For ligand blot analysis, 10 lg of the indicated puriﬁed proteins was
subjected to reducing 10% SDS–PAGE and staining with Coomassie
(lanes 1–3) or transfer to nitrocellulose membranes and incubation
with 125I His-LRPICD (lanes 4–6). Binding of 125I His-LRPICD to
GST-clone 17 and GST-MafB, but not to GST-D MafB, was detected
by autoradiography.
26 H.H. Petersen et al. / FEBS Letters 565 (2004) 23–27molecular details of these interactions and the proteins in-
volved are unclear [2,3]. Here, we report the ﬁrst experimental
system that enables high throughput screen for novel proteins
interacting with the LRPICD, overcoming major technical
obstacles encountered in conventional two-hybrid systems
before [12]. Using this screen, we report the functional inter-
action of the LRPICD with the transcription factor MafB,
suggesting a role for the receptor in transcriptional regulation
of hindbrain development.
Previously, a role for the LRPICD as an independent reg-
ulatory molecule has been proposed by studies that demon-
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activity [23]. Processing of the receptor tail is regulated by the
glycosylation pattern of the protein and by the presence of
adaptor proteins bound to it [14,23]. These ﬁndings suggest a
model whereby release of the ICD from the plasma membrane
may control signal transduction by translocating preformed
protein complexes to other subcellular compartments. In
support of this hypothesis, Kinoshita et al. [14] demonstrated
traﬃcking of the LRPICD to the nucleus where it negatively
aﬀects transcription through a complex of the APP-derived
ICD (APPICD) and the adaptor Fe65, likely by competition
with APPICD for the latter.
Our ﬁndings suggest MafB as an alternative transcriptional
pathway that is aﬀected by the LRPICD. MafB belongs to a
family of transcription factors that interact with other nuclear
proteins to regulate gene expression during embryonic devel-
opment and in cell diﬀerentiation processes. Interaction of Maf
proteins with other factors is crucial for Maf protein activity,
particularly because some of the Maf family members lack
obvious transactivation domains [21]. For example, MafB
regulates lineage speciﬁc gene expression in the hematopoietic
system by interacting with Ets transcription factor, suppressing
erythroid speciﬁc while stimulating monocyte speciﬁc diﬀer-
entiation processes [24,25].
Given the embryonic lethality observed in LRP knockout
mice [10], an established role for MafB in embryonic devel-
opment may be of particular relevance when considering in-
teraction of both proteins. MafB is the product of the murine
Kreisler gene, a recessive mutation that aﬀects hindbrain seg-
mentation [20]. Based on the ﬁndings obtained in HEK293
cells (Fig. 5), one may postulate a negative inﬂuence of
LRPICD on MafB transcription factor activity. The signiﬁ-
cant but modest inhibitory eﬀect of LRPICD on MafB activity
observed in this cell system may reﬂect the absence of addi-
tional co-factors that are required for this protein interaction
network and that may be expressed in a cell type speciﬁc
manner as shown for the hematopoietic system [24,25].
In conclusion, our studies have established a novel screening
system for proteins interacting with LRPICD that overcomes
limitations encountered in previous approaches and that will
signiﬁcantly facilitate the elucidation of the various receptor
functions. Furthermore, identiﬁcation of MafB as LRPICD
interacting protein supports a role of the tail domain as in-
dependent regulator of transcription in the nucleus and high-
lights possible mechanisms responsible for embryonic lethality
of the LRP1 knockout mouse model.Acknowledgements: We are indebted to C. R€ader, H. Schulz, and D.
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